Foreign asset managers are eyeing China’s vast pool of savings
ZHANG KUN is the rock star of Chinese fund management. His name often makes headlines; whole articles are dedicated to his investment calls. Investors vie to get into his funds, one of which has reportedly delivered a return of 700% since it was launched eight years ago. He is among a growing number of managers…
America’s wary approval of an Alzheimer’s drug offers hope to millions
Jun 7th 2021NEWS THAT America’s Food and Drug Administration (FDA) has granted conditional approval to a new drug, aducanumab, to be marketed as Aduhelm, for the treatment of Alzheimer’s disease, has understandably been greeted as a huge breakthrough. For millions of people with Alzheimer’s, a remorselessly degenerative illness leading eventually to utter helplessness—and for those…
America’s wary approval of an Alzheimer’s drug offers hope to millions
Jun 7th 2021NEWS THAT America’s Food and Drug Administration (FDA) has granted conditional approval to a new drug, aducanumab, to be marketed as Aduhelm, for the treatment of Alzheimer’s disease, has understandably been greeted as a huge breakthrough. For millions of people with Alzheimer’s, a remorselessly degenerative illness leading eventually to utter helplessness—and for those…